Thursday, 10 October 2013

Spain Pharmaceuticals and Healthcare Report Q4 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed 
Marketing on a budget?

Join the waiting list for our newest ebook on How to Run Ads on an Entrepreneur's Budget.
From our sponsors
Spain Pharmaceuticals and Healthcare Report Q4 2013
Oct 9th 2013, 00:00

Price: $ 1295  

BMI View: Despite the transfer of the financial burden of healthcare from the state to the patient going against the aim of most developed-state governments to provide social welfare, BMI believes the success of the measures in reducing public expenditure on drugs in Spain's pharmacy sector will mean the Spanish government implements more policies to reduce its contribution towards the cost of medicines. Furthermore, it is our view that ongoing public hospital debt issues will lead to the government enforcing further price erosion mechanisms on medicines in order to contain costs. Headline Expenditure Projections ? Pharmaceuticals: EUR24.99bn (US$31.74bn) in 2012 to EUR24.08bn (US$32.03bn) in 2013. ? Healthcare: EUR99.62bn (US$126.51bn) in 2012 to EUR99.09bn (US$131.79bn) in 2013; -0.5% in ...

Complete report details with Table of Contents and more @

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment